NexImmune
Pre-clinicalWith an urgent drive and singular focus on meeting the needs of waiting patients, our team is executing a bold strategy to deliver immunotherapies that go beyond incremental improvements to those with curative potential.
Focus
NanotechnologyCell & Gene Therapy
About
With an urgent drive and singular focus on meeting the needs of waiting patients, our team is executing a bold strategy to deliver immunotherapies that go beyond incremental improvements to those with curative potential.
Funding History
3Total raised: $125M
IPO$75MUndisclosedFeb 11, 2021
Series B$30MSynconaMar 15, 2020
Series A$20MSynconaJul 15, 2018
Company Info
TypePrivate
LocationUnited States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile